|
The Mississippi HOPE Strategy is our contribution to the effort to create a comprehensive, affordable prescription drug program for the senior citizens of Mississippi. It is a project of the Heinz Family Philanthropies, and was prepared in conjunction with PharmaCare, Johnson & Johnson, Eli Lilly & Company, GlaxoSmithKline, Merck & Co., Inc., Pfizer Inc., Pharmacia Corporation, Bayer Pharma, Aventis Pharma AG, AstraZeneca PLK, RiteAid Corporation, and Schering-Plough Corporation.
Jeffrey R. Lewis, Executive Director of the Heinz Family Philanthropies (jlewis@heinzoffice.org), prepared this report, with technical support from William M. Mercer, Incorporated.
To view the report, click the section titles below.
Back to Top
|
 |